Statin therapy with a documented history of coronary, cerebral or peripheral vascular disease, unless the patient’s status is end-of-life or established moderate or severe frailty. Angiotensin Converting Enzyme (ACE) inhibitor with coronary artery disease. Beta-blocker with symptomatic coronary artery disease. The gene discussed is ACE; the disease is peripheral vascular disease.